Source: Clinical and experimental immunology. Unidade: FM
Subjects: CITOCINA (ANÁLISE), PÂNCREAS (IMUNOLOGIA), DIABETES MELLITUS INSULINO-DEPENDENTE (DIAGNÓSTICO;IMUNOLOGIA), LINFÓCITOS T (ANÁLISE), AUTOANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GABBAY, M. Andrade Lima et al. Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients. Clinical and experimental immunology, n. 1, p. 60-67, 2012Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2249.2011.04538.x/pdf. Acesso em: 16 nov. 2024.APA
Gabbay, M. A. L., Sato, M. N., Duarte, A. J. S., & Dib, S. A. (2012). Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients. Clinical and experimental immunology, ( 1), 60-67. doi:10.1111/j.1365-2249.2011.04538.xNLM
Gabbay MAL, Sato MN, Duarte AJS, Dib SA. Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients [Internet]. Clinical and experimental immunology. 2012 ;( 1): 60-67.[citado 2024 nov. 16 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2249.2011.04538.x/pdfVancouver
Gabbay MAL, Sato MN, Duarte AJS, Dib SA. Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients [Internet]. Clinical and experimental immunology. 2012 ;( 1): 60-67.[citado 2024 nov. 16 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2249.2011.04538.x/pdf
